Biosyent Inc (RX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 90 | 183 | 418 | 75 | 62 |
| Receivables | 447 | 78 | 18 | 1,781 | 137 |
| Inventories | 48 | 70 | 110 | 81 | 71 |
| TOTAL | $595 | $742 | $582 | $1,938 | $271 |
| Non-Current Assets | |||||
| PPE Net | 24 | 32 | 40 | 32 | 42 |
| Intangibles | N/A | N/A | 102 | 237 | N/A |
| Other Non-Current Assets | 0 | 0 | 2 | 52 | 862 |
| TOTAL | $24 | $32 | $144 | $321 | $904 |
| Total Assets | $619 | $773 | $726 | $2,259 | $1,175 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 500 | N/A |
| Accounts payable and accrued liabilities | 242 | 167 | 104 | 768 | 464 |
| Other current liabilities | N/A | N/A | N/A | N/A | 500 |
| TOTAL | $313 | $167 | $104 | $1,268 | $964 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 71 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $313 | $167 | $104 | $1,268 | $964 |
| Shareholders' Equity | |||||
| Retained earnings | -6,572 | -6,260 | -5,845 | -5,473 | -6,254 |
| Other shareholders' equity | 24 | 24 | 24 | 24 | 24 |
| TOTAL | $306 | $607 | $622 | $991 | $210 |
| Total Liabilities And Equity | $619 | $773 | $726 | $2,259 | $1,175 |